Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Karin M. Kirschner
ExActa HIF Prolyl Hydroxylase Inhibitors – The New Lifestyle Drug?
Acta Physiologica
Physiology
Related publications
Expression and Actions of HIF Prolyl-4-Hydroxylase in the Rat Kidneys
AJP: Renal Physiology
Drug Discovery for Overcoming Chronic Kidney Disease (CKD): Prolyl-Hydroxylase Inhibitors to Activate Hypoxia-Inducible Factor (HIF) as a Novel Therapeutic Approach in CKD
Journal of Pharmacological Sciences
Molecular Medicine
Pharmacology
Substrate Preference of the HIF-prolyl Hydroxylase-2 (PHD2) and Substrate-Induced Conformational Change
Journal of Inorganic Biochemistry
Biochemistry
Inorganic Chemistry
Characterization of Different Isoforms of the HIF Prolyl Hydroxylase PHD1 Generated by Alternative Initiation
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitors: A Potential New Treatment for Anemia in Patients With CKD
American Journal of Kidney Diseases
Nephrology
Correction To: HIF Prolyl Hydroxylase Inhibition Protects Skeletal Muscle From Eccentric Contraction Induced Injury
Skeletal Muscle
Orthopedics
Sports Medicine
Cell Biology
Molecular Biology
Author Correction: Hypoxia-Inducible Factor (HIF) Prolyl Hydroxylase Inhibitors Induce Autophagy and Have a Protective Effect in an In-Vitro Ischaemia Model
Scientific Reports
Multidisciplinary
High Yield Production of Functional HIF Prolyl Hydroxylase Domain Proteins From Inclusion Body Expression in E. Coli
Biophysical Journal
Biophysics
Hypoxia-Inducible Factor (HIF)-prolyl Hydroxylase 3 (PHD3) Maintains High HIF2A mRNA Levels in Clear Cell Renal Cell Carcinoma
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
